ResearcherUniversity of L'AquilaNo recent work listed

Enrico Ricevuto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5641-3187; OpenAlex author ID A5082847339. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper

Papers 1

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safet… Last author DOI 10.18632/oncotarget.25870 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gemma Bruera · 1 shared paper, 2018 · strength 0.08
- Paper Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended … DOI 10.18632/oncotarget.25870 ↗
Antonio Dello Russo · 1 shared paper, 2018 · strength 0.08
- Paper Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended … DOI 10.18632/oncotarget.25870 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.